| Literature DB >> 33841544 |
Zahra Hashemi1, Sobhan Mortazavi-Derazkola2, Pouria Biparva3, Hamid Reza Goli4, Fereshteh Sadeghian1, Mostafa Kardan4, Alireza Rafiei4, Mohammad Ali Ebrahimzadeh1.
Abstract
Biogenic synthesis of silver nanoparticles (SNPs) has great attention of scientists, as it provides clean, biocompatible, non-toxic and inexpensive fabrication. In this study, F. sellowiana leaf extract was used for synthesizing SNPs which reduces silver nitrate into silver zero-valent. SNPs were characterized by UV, FTIR, XRD, SEM-EDS, and TEM analysis. They were also examined for their biological activities. The presence of biosynthesized SNPs was characterized by UV-visible spectroscopy and also crystal nature of SNPs was identified with XRD analysis. FT-IR spectrum was used to confirm the presence of different functional groups in the biomolecules which act as a capping agent for the nanoparticles. The morphology of SNPs was explored using SEM and the presence of silver was confirmed by elemental analysis. The size of the nanoparticles was in the range of 20-50 nm determined by TEM. The green synthesized SNPs showed good antibacterial activities against both gram-negative and gram-positive bacteria and also in resistant clinically isolated pathogens. Furthermore, the green synthesized SNPs showed reliable anticancer activity on the gastric adenocarcinoma (AGS) and breast (MCF-7) cancer cell lines with little effect on normal (HFF) cells. The in-vitro antioxidant activity of SNPs showed a significant effect on the scavenging of free radicals and iron chelating activity.Entities:
Keywords: Antibacterial; Anticancer; Antioxidant; Feijoa sellowiana; Green synthesis; Silver nanoparticles
Year: 2020 PMID: 33841544 PMCID: PMC8019869 DOI: 10.22037/ijpr.2020.112523.13805
Source DB: PubMed Journal: Iran J Pharm Res ISSN: 1726-6882 Impact factor: 1.696
Figure 1UV-visible spectrum of SNPs synthesis for optimization of (a) temperature (b) concentration of AgNO3 (c) pH (d) Time of reaction
Figure 2(a) TEM micrograph of the silver nanoparticles (b) EDS diagram (c) SEM micrograph at 200nm (d) Color changing after reaction which dark brown is synthesized SNPs
Figure 3(a) DLS (b) XRD pattern of synthesis SNPs
Figure 4FTIR spectra of SNPs
Antibacterial activities of NPs at ATCC bacteria strain
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| 9.5 | 0.3 | >4000 | 0.21 | ATCC 29213 |
|
| 37 | 18 | >4000 | 0.21 | ATCC 29212 |
|
| 4.5 | 0.6 | >4000 | 512 | ATCC 27853 |
|
| 0.6 | 0.3 | >4000 | 0.25 | ATCC 19606 |
|
| 9.5 | 0.6 | >4000 | 0.1 | ATCC 25922 |
|
| 9.5 | 0.6 | >4000 | 0.1 | ATCC 700603 |
|
| 4.5 | 0.6 | >4000 | 0.1 | ATCC 25933 |
|
Antibacterial activities of NPs at clinically isolated and resistant strains
|
|
|
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| R | S | R | R | R | R | R | R | R | R | R | 1.17 | 18.75 |
|
| R | R | R | R | S | R | R | R | R | R | S | 0.58 | 9.37 |
|
| R | R | R | R | R | R | R | R | R | R | R | 0.58 | 4.8 |
|
| R | R | R | R | R | R | R | R | R | R | R | 0.58 | 9.37 |
|
| R | R | R | R | R | R | R | R | R | R | R | 0.58 | 18.75 |
|
| R | R | R | R | R | R | R | R | R | R | R | 9.37 | 150 |
|
| R | R | R | R | R | R | R | R | R | R | R | 1.17 | 9.37 |
|
MC, Meticillin; VC, Vancomycin; OC, Oxacillin; TC, Tetracycline; GM, Gentamicin; PC, Penicillin; CIF, Ciprofloxacin; CEZ, Ceftazidime; ERM, Erythromycin; CM, Clindamycin; AK, Amikacin
Figure 5Cytotoxicity assay of the prepared SNPs against MCF-7, AGS, HFF cell lines *Doxorubicin 1mM and 5mM